Latest News

Analysts say that despite a new loan, Brazil's CSN assets sales are still urgent.

Analysts on Monday said that a $1.2 billion bridge-loan secured by Brazilian steelmaker CSN last week from banks does not ease the group's need to sell assets in the near future and deal with its ballooning debt. Analyst?Pedro?Galdi at AGF said that the company is in a "firefighting mode". He expects that the company will continue to prioritize divestments in order to raise up 18 billion reais (about $3 billion) and reduce its debt. CSN reported recently that this debt had exceeded 40 billion reais.

The company signed a binding agreement with a group banks at the end of the week for a credit facility worth $1.2 billion that could increase to $1.4.

CSN announced in a statement released over the weekend that it plans to 'use the proceeds to refinance current debt and to pay fees, expenses, and other costs associated with the facility.' The initiative, they added, is part of an broader deleveraging program announced?in January.

Igor Guedes is an analyst with Genial Investimentos, a Sao Paulo-based investment firm. He said that the bridge loan was a temporary solution to the company's problems, but it still remains under pressure. CSN's Chief Financial Officer Marco Rabello stated earlier this month that the company expected to complete the sale control of CSN Cimentos and a stake in their future logistics assets company in the third-quarter.

The transactions are part a?plan to raise between 15 and 18 billion reais in capital this year to reduce financial risk.

Rabello stated that CSN hired Morgan Stanley for advice on the sale control of CSN Cimentos, and Bradesco and Citibank were mandated to provide advice on "the process" involving their logistics company.

Three people familiar with negotiations say Morgan Stanley has been in talks with both local and international companies about the sale of cement units, including Brazil's Votorantim, and J&F S.A. which controls JBS and the holding company J&F S.A.

Morgan Stanley, Votorantim and J&F have declined to comment. CSN had no immediate comment. (Reporting and additional reporting by Alberto Alerigi Jr.; editing by Andrei Khalip.)

(source: Reuters)